2012
DOI: 10.3390/ijms13021710
|View full text |Cite
|
Sign up to set email alerts
|

Screening of Crude Plant Extracts with Anti-Obesity Activity

Abstract: Obesity is a global health problem. It is also known to be a risk factor for the development of metabolic disorders, type 2 diabetes, systemic hypertension, cardiovascular disease, dyslipidemia, and atherosclerosis. In this study, we screened crude extracts from 400 plants to test their anti-obesity activity using porcine pancreatic lipase assay (PPL; triacylglycerol lipase, EC 3.1.1.3) in vitro activity. Among the 400 plants species examined, 44 extracts from plants, showed high anti-lipase activity using 2,4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
71
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 122 publications
(80 citation statements)
references
References 28 publications
3
71
0
1
Order By: Relevance
“…1 saturated fat, high calorie content), and sedentary lifestyles. 2 Individual is considered obese when the amount of fat tissue is increased to such an extent that physical and mental health are affected and life expectancy reduced.…”
Section: Introductionmentioning
confidence: 99%
“…1 saturated fat, high calorie content), and sedentary lifestyles. 2 Individual is considered obese when the amount of fat tissue is increased to such an extent that physical and mental health are affected and life expectancy reduced.…”
Section: Introductionmentioning
confidence: 99%
“…[21] Also, porcine pancreatic lipase (type-II) inhibitory activity of the samples was determined using p-nitrophenyl butyrate (p-NPB) as substrate. [27] In brief, enzyme solution (1 mg/mL) was prepared in 50 mM Tris-HCl (pH 8.0). Test solution (25 µL) was mixed with lipase solution (50 µL) in a 96-well microplate and incubated for 20 min at 25°C.…”
Section: Antioxidant Assaysmentioning
confidence: 99%
“…The success of orlistat encouraged the development of PL inhibitors as weight-reducing drugs. In new weight-reducing therapies with more potency or fewer side effects, several natural PL inhibitors, such as platycodin saponins, scabiosaponins, chikusetsusaponins, tea saponins, assamicain A, oolonghomobisflavan A, and oolonghomobisflavan B, have been identified as inhibitors of PL activity in vitro (de la Garza et al, 2011;Han et al, 1999Han et al, ,2005Roh & Jung, 2012;Slanc et al, 2009;Zhao & Kim, 2004;Zheng et al, 2004). However, the compounds are difficult to develop as antiobesity drugs because of limited sources.…”
Section: Introductionmentioning
confidence: 99%